基本信息
views: 20
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
We conduct both basic and clinical research programs, focused primarily on development of pathogenesis-driven molecular diagnostics and therapeutics for rare lung diseases. We are an integral part of the Translational Pulmonary Science Center, which is a collaborative project between pulmonary groups at UC and CCHMC, the Rare Lung Diseases Consortium (PIs Trapnell and McCormack), an NIH and NCATs supported platform for conducting studies in rare lung disease.
In our basic research, all projects have a human clinic trial on the horizon, at least conceptually. The laboratory has used mouse models of pulmonary Langerhans cell histiocytosis, Hermansky Pudlak syndrome, lymphangioleiomyomatosis, and pulmonary alveolar microlithiasis in preclinical studies to determine mechanisms of alveolar homeostasis in health and disease. We are also interested in the role of pulmonary airway cells, collectins and lung epithelial cells in innate immune defense against inhaled bacteria, mycobacteria, fungi and viruses, especially (and most recently) influenza.
Our clinical research is focused on investigator-initiated, multicenter, international randomized trials for lymphangioleiomyomatosis, one of which recently led to discovery of an effective treatment and to FDA approval. We are optimistic that our laboratory findings will support the design and execution of trials of phosphate restriction for pulmonary alveolar microlithiasis, BRAF inhibitors for pulmonary Langerhans cell histiocytosis, KGF treatment for pulmonary non tuberculous mycobacterial disease, and mTOR inhibitor prophylaxis and therapy for influenza.
Research Interests
Papers共 396 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
K.J. Noonan, R.T. Hearne, D.J. Murphy,B. Gaffney, B. Sheehy, N. McVeigh,A.N. Franciosi,M.P. Keane, A. Ataya, N. Gupta,F.X. Mccormack,F. Bonella,
C23. MACHINE LEARNED: AI-DRIVEN SOLUTIONS IN ILD AND LUNG TRANSPLANT (2024)
M. Penugonda,M. O'Callaghan,R. Diesler, H. O'Brien,H. Almeamar,B.F. Samhouri,J.H. Ryu,E. Bendstrup,T.K. Lund,H.H.L. Schultz,M. Veltkamp,E.D. Manali,
C72. CASE REPORTS IN RESPIRATORY STRUCTURE AND FUNCTION (2024)
Endocrine-related cancerno. 6 (2024)
A. Jose, N. Rahman, A. Opotowsky,T. Glorioso,S. Waldo, K. Zeder, A. Seto,J.M. Elwing,F.X. McCormack, B. Maron
B24. WHALE WATCHING: A “RAPID” TOUR OF PAH PATHOGENESIS (2024)
C24. CLINICAL, BIOLOGIC, AND RADIOLOGIC MARKERS OF KEY OUTCOMES AND TREATMENT RESPONSE IN COPD (2024)
Springer eBookspp.177-192, (2023)
Cited0Views0Bibtex
0
0
European respiratory review : an official journal of the European Respiratory Societyno. 169 (2023): 230100-230100
Springer eBookspp.251-274, (2023)
Cited0Views0Bibtex
0
0
Journal of the Endocrine Societyno. Supplement_1 (2023)
Santhoshi V Akkenepally,Dan J K Yombo,Sanjana Yerubandi,Geereddy Bhanuprakash Reddy,Deepak A Deshpande,Francis X McCormack,Satish K Madala
Nature communicationsno. 1 (2023): 8207-8207
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn